Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy and safety of Xinyue Capsule for heart failure with preserved ejection fraction; the study is currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xinyue Capsule

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING